Oncology International (India) Private Limited, a active private limited company, was established on 02 September 2011 in Anekal, Karnataka, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85100KA2011PTC060215. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Employing 12 professional, Its leadership includes Adithya Nanjunda (Additional Director), Vinay Nagaraja Sarode (Director), Pundaleeka Krishnappa Sarode (Additional Director). Past directors included Anup Pundaleeka Sarode, Sarode Krishnappa Nagaraja. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 282/1/F, Kiadb Industrial Area, Opp To Hcl Technologies Pvt Ltd, Bommasandra, Anekal, Karnataka, 560105.
U85100KA2011PTC060215
060215
02 September 2011
₹5.00 M
₹5.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Oncology International (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Adithya Nanjunda | Additional Director | 21 Aug 2024 | Current |
| Vinay Nagaraja Sarode | Director | 02 Sep 2011 | Current |
| Pundaleeka Krishnappa Sarode | Additional Director | 16 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 22 Sep 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oncology International (India) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 44.63% decrease. The company also saw a substantial fall in profitability, with a 298.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 69.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Oncology International (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Oncology International (India) has a workforce of 12 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oncology International (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncology International (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pundaleeka Krishnappa Sarode was appointed as a Additional Director was appointed as a Additional Director on 16 Jun 2025 & has been associated with this company since 5 months 15 days . was recorded as a recent event.
Oncology International (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Adithya Nanjunda was appointed as a Additional Director was appointed as a Additional Director on 21 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
Progress on Oncology International (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity Vinay Nagaraja Sarode was appointed as a Director was appointed as a Director on 02 Sep 2011 & has been associated with this company since 14 years 2 months . was completed.
The activity Oncology International (India) Private Limited was registered on 02 Sep 2011 with Roc Bangalore & aged 14 years 2 months as per MCA records. was completed.
The CIN of Oncology International (India) Private Limited is U85100KA2011PTC060215.
Oncology International (India) Private Limited is headquartered at 282/1/F, Kiadb Industrial Area, Opp To Hcl Technologies Pvt Ltd, Bommasandra, Anekal, Karnataka, 560105.
Oncology International (India) Private Limited was incorporated on 02 September 2011.
The current directors of Oncology International (India) Private Limited are
The primary industry of Oncology International (India) Private Limited is Hospital And Medical Care.
Oncology International (India) Private Limited is unlisted.
The authorized capital of Oncology International (India) Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Oncology International (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX